Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
National Institutes of Health · National Cancer Institute · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
815
total citations
- FWCI
- 30.14
- Percentile
- 100%
- References
- 28
Citations per year
Authors
22- AGAustin G. Duffy
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- SVSusanna V. Ulahannan
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- OMOxana Makorova-Rusher
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- OEOsama E. Rahma
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- HWHeiner Wedemeyer
Medizinische Hochschule Hannover
Topics & keywords
Topics
Keywords
- Tremelimumab
- Medicine
- Hepatocellular carcinoma
- Internal medicine
- Gastroenterology
- CD8
- Refractory (planetary science)
- Ablation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.